Genetic susceptibility to Behcet's disease: role of genes belonging to the MHC region.
暂无分享,去创建一个
[1] Yoonosuke Watanabe,et al. Behcet's Disease , 2019, Definitions.
[2] N. Zhai,et al. Study on association between polymorphism of HLA‐DRB1 alleles and Behçet's disease , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.
[3] L. Guillevin,et al. HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies. , 2009, Arthritis and rheumatism.
[4] S. Dastgiri,et al. TNF-α gene polymorphisms in Iranian Azeri Turkish patients with Behcet’s Disease , 2009, Rheumatology International.
[5] H. Inoko,et al. Genetics of Behçet disease inside and outside the MHC , 2009, Annals of the rheumatic diseases.
[6] G. Wallace. Novel genetic analysis in Behçet's disease , 2009, Arthritis research & therapy.
[7] S. Gabriel,et al. Epidemiology and clinical characteristics of Behçet's disease in the US: a population-based study. , 2009, Arthritis and rheumatism.
[8] Beth Cobb,et al. Identification of novel genetic susceptibility loci for Behçet's disease using a genome-wide association study , 2009, Arthritis research & therapy.
[9] H. Oral,et al. Cytokine gene polymorphisms in Behçet's disease and their association with clinical and laboratory findings. , 2009, Clinical and experimental rheumatology.
[10] S. Tsai,et al. A genetic study of Behçet's disease in Taiwan Chinese. , 2008, Tissue antigens.
[11] H. Inoko,et al. Re-evaluation of heterogeneity in HLA-B*510101 associated with Behçet's disease. , 2008, Tissue antigens.
[12] D. Mendonça,et al. New insights of HLA class I association to Behçet's disease in Portuguese patients. , 2008, Tissue antigens.
[13] B. Yalçın,et al. The functional role of nuclear factor kappa‐κB1 −94 ins/del ATTG promotor gene polymorphism in Behçet’s disease: an exploratory study , 2008, Clinical and experimental dermatology.
[14] R. Vonthein,et al. IL-6 receptor, IL-8 receptor and TNF-alpha238 (G/A) polymorphisms are not associated with Behçet's disease in patients of German or Turkish origin. , 2008, Clinical and experimental rheumatology.
[15] C. Farra,et al. TNF polymorphisms in Lebanese patients with Behçet's disease. , 2008, Clinical and experimental rheumatology.
[16] Bjoern Peters,et al. HLA class I supertypes: a revised and updated classification , 2008, BMC Immunology.
[17] I. Tohnai,et al. Association of Major Histocompatibility Complex Class I Chain-Related Gene A and HLA-B Alleles with Behçet's Disease in Turkey , 2007, Japanese Journal of Ophthalmology.
[18] S. Sohn,et al. Association of CD94/NKG2A, CD94/NKG2C, and its ligand HLA-E polymorphisms with Behcet's disease. , 2007, Tissue antigens.
[19] M. Houman,et al. Tumor necrosis factor gene polymorphisms in Tunisian patients with Behcet's disease. , 2007, Human immunology.
[20] A. Fraser,et al. Prevalence and clinical aspects of Behcet’s disease in the north of Israel , 2007, Clinical Rheumatology.
[21] I. Olivieri,et al. Epidemiology and clinical course of Behçet's disease in the Reggio Emilia area of Northern Italy: a seventeen-year population-based study. , 2007, Arthritis and rheumatism.
[22] S. Sohn,et al. HLA-E*0101 and HLA-G*010101 reduce the risk of Behcet's disease. , 2007, Tissue antigens.
[23] Y. Bek,et al. T helper 1 type cytokines polymorphisms: association with susceptibility to Behçet’s disease , 2007, Clinical Rheumatology.
[24] W. Jang,et al. The novel –G646A polymorphism of the TNFα promoter is associated with the HLA‐B51 allele in Korean patients with Behçet's disease , 2007, Scandinavian journal of rheumatology.
[25] H. Direskeneli. Autoimmunity vs autoinflammation in Behcet's disease: do we oversimplify a complex disorder? , 2006, Rheumatology.
[26] H. Gollnick,et al. Prevalence of Adamantiades-Behçet's disease in Germany and the municipality of Berlin: results of a nationwide survey. , 2006, Clinical and experimental rheumatology.
[27] D. Bang,et al. Increased risk of human leukocyte antigen-G gene variants in Behçet's disease. , 2006, Clinical and experimental rheumatology.
[28] Nayoung Kim,et al. Association of TNFA Promoter Region Haplotype in Behçet's Disease , 2006, Journal of Korean medical science.
[29] E. Alpsoy,et al. TNF‐α gene 1031 T/C polymorphism in Turkish patients with Behçet's disease , 2006 .
[30] G. Espinosa,et al. Allelic Diversity and Affinity Variants of MICA are Imbalanced in Spanish Patients with Behçet's Disease , 2006, Scandinavian journal of immunology.
[31] Jerzy K. Kulski,et al. Four-digit allele genotyping of the HLA-A and HLA-B genes in Japanese patients with Behcet's disease by a PCR-SSOP-Luminex method. , 2006, Tissue antigens.
[32] K. Nakae,et al. Microsatellite polymorphisms of the MICA gene among Japanese patients with Behçet's disease. , 2006, Canadian journal of ophthalmology. Journal canadien d'ophtalmologie.
[33] M. Duman,et al. Lack of association of tumor necrosis factor-alpha gene polymorphisms with disease susceptibility and severity in Behçet’s disease , 2006, Rheumatology International.
[34] R. Vaughan,et al. Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet's disease in Caucasian patients. , 2005, Tissue antigens.
[35] K. Kim,et al. Interleukin-18 gene polymorphisms in Korean patients with Behçet's disease. , 2005, Clinical and experimental rheumatology.
[36] A. Silman,et al. Whole-genome screening for susceptibility genes in multicase families with Behçet's disease. , 2005, Arthritis and rheumatism.
[37] H. Inoko,et al. Autoreactive CD8+ cytotoxic T lymphocytes to major histocompatibility complex class I chain-related gene A in patients with Behçet's disease. , 2004, Arthritis and rheumatism.
[38] C. Aliaǧaoǧlu,et al. HLA class I and class II genotyping in patients with Behcet's disease: a regional study of eastern part of Turkey. , 2004, Tissue antigens.
[39] Ö. Pamuk,et al. Prevalence of Behçet's disease in rural western Turkey: a preliminary report. , 2004, Clinical and experimental rheumatology.
[40] H. Nagafuchi,et al. Abnormal killer inhibitory receptor expression on natural killer cells in patients with Behçet's disease , 2004, Rheumatology International.
[41] E. Soto-Vega,et al. Class I and class II MHC polymorphisms in Mexican patients with Behçet's disease. , 2004, Immunology letters.
[42] J. Kalil,et al. MICA polymorphism in a sample of the São Paulo population, Brazil. , 2004, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.
[43] A. Gül,et al. Prevalence of Behçet's disease in Istanbul, Turkey , 2003, International journal of dermatology.
[44] J. Daurès,et al. Identification of an autosomal recessive mode of inheritance in paediatric Behçet's families by segregation analysis , 2003, American journal of medical genetics. Part A.
[45] U. Ozbek,et al. Tumour necrosis factor-alpha gene promoter region -308 and -376 G-->A polymorphisms in Behçet's disease. , 2003, Clinical and experimental rheumatology.
[46] M. Stanford,et al. Behçet’s disease in patients of west African and Afro-Caribbean origin , 2003, The British journal of ophthalmology.
[47] E. Lee,et al. TNF and TNF receptor polymorphisms in Korean Behcet's disease patients. , 2003, Human immunology.
[48] F. Takeuchi,et al. Association of Transporter Associated with Antigen Processing Genes with Behçet's Disease in Japanese , 2003, Autoimmunity.
[49] T. Ahmad,et al. Mapping the HLA association in Behçet's disease: a role for tumor necrosis factor polymorphisms? , 2003, Arthritis and rheumatism.
[50] H. Inoko,et al. Analysis of microsatellite polymorphism around the HLA-B locus in Iranian patients with Behçet's disease. , 2002, Tissue antigens.
[51] R. Ravazzolo,et al. MICA gene polymorphisms in an Italian paediatric series of juvenile Behçet disease. , 2002, International journal of molecular medicine.
[52] J. Barrett,et al. A weak association of HLA-B*2702 with Behçet’s disease , 2002, Genes and Immunity.
[53] Kyung-Su Park,et al. Association of MICA polymorphism with HLA-B51 and disease severity in Korean patients with Behcet's disease. , 2002, Journal of Korean medical science.
[54] Lutfi Jaber,et al. Prevalence of Behçet's disease in an Arab community in Israel , 2002, Annals of the rheumatic diseases.
[55] H. Inoko,et al. Sequencing-based typing of HLA-B*51 alleles and the significant association of HLA-B*5101 and -B*5108 with Behçet's disease in Greek patients. , 2002, Tissue antigens.
[56] S. Metzger,et al. Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel , 2002, Annals of the rheumatic diseases.
[57] F. Spertini,et al. Behçet’s disease in Western Switzerland: Epidemiology and analysis of ocular involvement , 2002, Ocular immunology and inflammation.
[58] H. Direskeneli. Behçet's disease: infectious aetiology, new autoantigens, and HLA-B51 , 2001, Annals of the rheumatic diseases.
[59] Y. Molad,et al. Allelic distribution of HLA-B*5 in HLA-B5-positive Israeli patients with Behçet's disease. , 2001, Tissue antigens.
[60] H. Inoko,et al. HLA-B*51 allele analysis by the PCR-SBT method and a strong association of HLA-B*5101 with Japanese patients with Behçet's disease. , 2001, Tissue antigens.
[61] C. Zouboulis,et al. Comparative analysis of the association of HLA-B*51 suballeles with Behçet's disease in patients of German and Turkish origin. , 2001, Tissue antigens.
[62] I. Olivieri,et al. Association of MICA alleles and HLA-B51 in Italian patients with Behçet's disease. , 2001, The Journal of rheumatology.
[63] H. Inoko,et al. Microsatellite mapping of a susceptible locus within the HLA region for Behçet's disease using Jordanian patients. , 2001, Human immunology.
[64] S. Caillat-Zucman,et al. HLA-B*51 and B*15 alleles confer predisposition to Behçet's disease in Moroccan patients. , 2001, Human immunology.
[65] H. Inoko,et al. Localization of the pathogenic gene of Behçet's disease by microsatellite analysis of three different populations. , 2000, Investigative ophthalmology & visual science.
[66] H. Inoko,et al. Significant associations of HLA-B*5101 and B*5108, and lack of association of class II alleles with Behçet's disease in Italian patients. , 1999, Tissue antigens.
[67] Gen Tamiya,et al. Complete sequence and gene map of a human major histocompatibility complex , 1999 .
[68] H. Inoko,et al. Association analysis between the MIC-A and HLA-B alleles in Japanese patients with Behçet's disease. , 1999, Arthritis and rheumatism.
[69] S. Ohno,et al. Behçet's disease, the Silk Road and HLA-B51: historical and geographical perspectives. , 1999, Tissue antigens.
[70] R. Vaughan,et al. HLA and tumour necrosis factor (TNF) polymorphisms in ocular Behçet's disease. , 1999, Tissue antigens.
[71] H. Inoko,et al. HLA class I and II typing of the patients with Behçet's disease in Saudi Arabia. , 1999, Tissue antigens.
[72] J. Sánchez-Román,et al. Lack of association of MICA transmembrane region polymorphism and Behçet's disease in Spain. , 1999, Tissue antigens.
[73] H. Inoko,et al. Association of MICA gene and HLA-B*5101 with Behçet's disease in Greece. , 1999, Investigative ophthalmology & visual science.
[74] I. Touitou,et al. Familial aggregation in Behçet's disease: high frequency in siblings and parents of pediatric probands. , 1999, The Journal of pediatrics.
[75] Nobuhisa Mizuki,et al. MIC-A allele profiles and HLA class I associations in Behçet's disease , 1999, Immunogenetics.
[76] H. Inoko,et al. The critical region for Behçet disease in the human major histocompatibility complex is reduced to a 46-kb segment centromeric of HLA-B, by association analysis using refined microsatellite mapping. , 1999, American journal of human genetics.
[77] G. Tamiya,et al. Microsatellite polymorphism within the MICB gene among Japanese patients with Behçet's disease. , 1998, Human immunology.
[78] J. Sánchez-Román,et al. Association of HLA-B51 subtypes and Behçet's disease in Spain. , 1998, Tissue antigens.
[79] M. Spyropoulou,et al. HLA-B*5101 in Greek patients with Behçet's disease. , 1998, Human immunology.
[80] E. Alpsoy,et al. HLA Antigens and Linkage Disequilibrium Patterns in Turkish Behçet's Patients , 1998, The Journal of dermatology.
[81] H. Gollnick,et al. Epidemiological features of Adamantiades-Behçet's disease in Germany and in Europe. , 1997, Yonsei medical journal.
[82] H. Inoko,et al. A strong association between HLA-B*5101 and Behçet's disease in Greek patients. , 1997, Tissue antigens.
[83] R. Lawrence,et al. Class I HLA antigens in spondyloarthropathy: observations in Alaskan Eskimo patients and controls. , 1997, The Journal of rheumatology.
[84] M. Yamazaki,et al. Triplet repeat polymorphism in the transmembrane region of the MICA gene: a strong association of six GCT repetitions with Behçet disease. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[85] S. Ohno,et al. LMP7 polymorphism in Japanese patients with sarcoidosis and Behçet's disease. , 1996, Human immunology.
[86] H. Inoko,et al. HLA-C genotyping of patient with Behçet's disease in the Japanese population. , 1996, Human immunology.
[87] J. Sanderson,et al. Role of γδ T cells in pathogenesis and diagnosis of Behçet's disease , 1996, The Lancet.
[88] T. Shiina,et al. Allelic variations in the TAP2 and LMP2 genes in Behçet's disease. , 1996, Tissue antigens.
[89] H. Direskeneli,et al. Neutrophil adhesion to endothelial cells and factors affecting adhesion in patients with Behçet's disease. , 1996, Annals of the rheumatic diseases.
[90] N. Sayınalp,et al. Cytokines in Behçet's disease. , 1996, The Journal of rheumatology.
[91] S. Ohno,et al. Microsatellite polymorphism between the tumor necrosis factor and HLA-B genes in Behçet's disease. , 1995, Human immunology.
[92] V. Gnau,et al. Peptide motifs of HLA-B51, -B52 and -B78 molecules, and implications for Behćet's disease. , 1995, International immunology.
[93] W. Jacyk. Behçet's disease in South African blacks: report of five cases. , 1994, Journal of the American Academy of Dermatology.
[94] H. Inoko,et al. Behçet's disease associated with one of the HLA-B51 subantigens, HLA-B* 5101. , 1993, American journal of ophthalmology.
[95] E. Hedfors,et al. Behçet's disease: a review and a report of 12 cases from Sweden. , 1993, Acta dermato-venereologica.
[96] C. Chiang,et al. HLA-DR and DQ antigens in Chinese patients with Behçet's disease. , 1993, Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology.
[97] S. Ohno,et al. Human leukocyte antigen serologic and DNA typing of Behçet's disease and its primary association with B51. , 1992, Investigative ophthalmology & visual science.
[98] H. Inoko,et al. RFLP analysis in the TNF-beta gene and the susceptibility to alloreactive NK cells in Behçet's disease. , 1992, Investigative ophthalmology & visual science.
[99] X. Jian,et al. Histocompatibility antigens associated with Behçet's disease in northern Han Chinese. , 1992, Internal medicine.
[100] I. Crombie,et al. Behçet's syndrome in Scotland. , 1992, Postgraduate medical journal.
[101] K. Hoshi,et al. Increased peripheral blood gamma delta+ T cells and natural killer cells in Behçet's disease. , 1992, The Journal of rheumatology.
[102] M. Rubini,et al. Serological and molecular HLA typing in Italian Behçet's patients: significant association to B51-DR5-DQw3 haplotype. , 1992, Tissue antigens.
[103] Z. Meiner,et al. Close association of HLA-B51 and B52 in Israeli patients with Behçet's syndrome. , 1991, Annals of the rheumatic diseases.
[104] Denis Wakefield,et al. Behset's syndrome: ocular features in an Australian population , 1990 .
[105] A. Al-Dalaan,et al. BEHÇET'S DISEASE IN SAUDI ARABIA. , 1989 .
[106] K. Ayed,et al. Behçet's disease and major histocompatibility complex class II antigens in Tunisians. , 1988, Disease markers.
[107] K. Sharquie,et al. Behçet's disease in Iraqi patients. , 1986, Annals of the rheumatic diseases.
[108] L. Melchiorri,et al. Behcet's disease associated with HLA-B51 and DRw52 antigens in Italians. , 1986, Human immunology.
[109] Moore Sb,et al. Lack of association between Behçet's disease and major histocompatibility complex class II antigens in an ethnically diverse North American Caucasoid patient group. , 1986 .
[110] H. Matsuda,et al. Close association of HLA-Bw51 with Behçet's disease. , 1982, Archives of ophthalmology.
[111] B. Schwartz,et al. A public antigenic determinant in the HLA-B5 cross-reacting group--a basis for cross-reactivity and a possible link with Behcet's disease. , 1980, Human immunology.
[112] S. Ohno,et al. HLA-Bw51 and Behçet's disease. , 1978, JAMA.
[113] M. Chamberlain. Behcet's syndrome in 32 patients in Yorkshire. , 1977, Annals of the rheumatic diseases.
[114] E. Alpsoy,et al. TNF-alpha gene 1031 T/C polymorphism in Turkish patients with Behçet's disease. , 2006, The British journal of dermatology.
[115] J. Sánchez-Román,et al. TAP polymorphism in patients with Behet'fs disease , 2004 .
[116] D Middleton,et al. New allele frequency database: http://www.allelefrequencies.net. , 2003, Tissue antigens.
[117] A. Silman,et al. Evidence for linkage of the HLA-B locus in Behçet's disease, obtained using the transmission disequilibrium test. , 2001, Arthritis and rheumatism.
[118] Young Keun Kim,et al. Copyright � The Korean Academy of Medical Sciences Epidemiologic and Clinical Survey of Behcet's Disease in Korea: the First Multicenter Study , 2001 .
[119] Elena S. Babaylova,et al. Complete sequence and gene map of a human major histocompatibility complex , 1999, Nature.
[120] C. Vilches,et al. HLA-Cw*1602: a new susceptibility marker of Behçet's disease in southern Spain. , 1998, Tissue antigens.
[121] N. Yamashita,et al. Hyperreactivity of neutrophils and abnormal T cell homeostasis: a new insight for pathogenesis of Behçet's disease. , 1997, International reviews of immunology.
[122] T. Lehner,et al. Role of gamma delta T cells in pathogenesis and diagnosis of Behcet's disease. , 1996, Lancet.
[123] H. Yazıcı,et al. The prevalence of Behçet's syndrome in a rural area in northern Turkey. , 1988, The Journal of rheumatology.
[124] S. Moore,et al. Lack of association between Behçet's disease and major histocompatibility complex class II antigens in an ethnically diverse North American Caucasoid patient group. , 1986, The Journal of rheumatology.